PL367040A1 - Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor - Google Patents
Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptorInfo
- Publication number
- PL367040A1 PL367040A1 PL02367040A PL36704002A PL367040A1 PL 367040 A1 PL367040 A1 PL 367040A1 PL 02367040 A PL02367040 A PL 02367040A PL 36704002 A PL36704002 A PL 36704002A PL 367040 A1 PL367040 A1 PL 367040A1
- Authority
- PL
- Poland
- Prior art keywords
- adrenoceptor
- alpha
- prevention
- treatment
- compounds useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30644901P | 2001-07-20 | 2001-07-20 | |
| FI20011560A FI116940B (fi) | 2001-07-20 | 2001-07-20 | Alfa-2B-adrenoseptorivälitteisen sairauden hoitoon tai ehkäisyyn käyttökelpoiset yhdisteet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL367040A1 true PL367040A1 (en) | 2005-02-21 |
Family
ID=26161203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02367040A PL367040A1 (en) | 2001-07-20 | 2002-07-22 | Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1417182A1 (es) |
| JP (1) | JP2004535467A (es) |
| CA (1) | CA2454187A1 (es) |
| HU (1) | HUP0401076A2 (es) |
| IL (1) | IL159511A0 (es) |
| MX (1) | MXPA04000615A (es) |
| NZ (1) | NZ530366A (es) |
| PL (1) | PL367040A1 (es) |
| RU (1) | RU2004105035A (es) |
| WO (1) | WO2003008387A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI118265B (fi) * | 2004-01-15 | 2007-09-14 | Jurilab Ltd Oy | Menetelmä akuutin sydäninfarktin ja sepelvaltimotaudin riskin havaitsemiseksi |
| PL1861101T3 (pl) | 2005-03-23 | 2013-06-28 | Klat Pharma Animal Health Gmbh | Zastosowanie amidów sulfadymidyny do leczenia chorób jelitowych u zwierząt |
| EA202091020A1 (ru) | 2017-10-24 | 2020-07-24 | Байер Акциенгезельшафт | Замещенные имидазопиридинамиды и их применение |
| WO2020216669A1 (de) | 2019-04-23 | 2020-10-29 | Bayer Aktiengesellschaft | Phenylsubstituierte imidazopyridinamide und ihre verwendung |
| CN116396236A (zh) * | 2023-04-19 | 2023-07-07 | 河北科技大学 | 一种二芳基甲基磺胺类化合物及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2086544C1 (ru) * | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
| US6150389A (en) * | 1994-07-11 | 2000-11-21 | Allergan Sales, Inc. | Comformationally rigid bicyclic and adamantane derivatives useful as α2 -adrenergic blocking agents |
| JP2003522148A (ja) * | 2000-02-11 | 2003-07-22 | オサケユイチア ユバンティア ファーマ リミティド | アルファ−２ｂ−アドレナリン受容体を媒介する疾患の処置又は予防に有用な化合物 |
| KR20020089493A (ko) * | 2000-04-28 | 2002-11-29 | 상꾜 가부시키가이샤 | ＰＰＡＲγ모듈레이터 |
-
2002
- 2002-07-22 NZ NZ530366A patent/NZ530366A/en unknown
- 2002-07-22 IL IL15951102A patent/IL159511A0/xx unknown
- 2002-07-22 WO PCT/FI2002/000643 patent/WO2003008387A1/en not_active Application Discontinuation
- 2002-07-22 RU RU2004105035/04A patent/RU2004105035A/ru not_active Application Discontinuation
- 2002-07-22 EP EP02748902A patent/EP1417182A1/en not_active Withdrawn
- 2002-07-22 HU HU0401076A patent/HUP0401076A2/hu unknown
- 2002-07-22 MX MXPA04000615A patent/MXPA04000615A/es unknown
- 2002-07-22 JP JP2003513947A patent/JP2004535467A/ja not_active Withdrawn
- 2002-07-22 PL PL02367040A patent/PL367040A1/xx not_active Application Discontinuation
- 2002-07-22 CA CA002454187A patent/CA2454187A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0401076A2 (hu) | 2004-09-28 |
| MXPA04000615A (es) | 2004-04-20 |
| CA2454187A1 (en) | 2003-01-30 |
| IL159511A0 (en) | 2004-06-01 |
| WO2003008387A1 (en) | 2003-01-30 |
| JP2004535467A (ja) | 2004-11-25 |
| EP1417182A1 (en) | 2004-05-12 |
| NZ530366A (en) | 2005-02-25 |
| RU2004105035A (ru) | 2005-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL160884A0 (en) | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease | |
| IL159344A0 (en) | Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease | |
| IL144101A0 (en) | Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin d2 | |
| AU2001282873A1 (en) | Quinuclidine-substituted aryl compounds for treatment of disease | |
| EP1594512A4 (en) | COMPOUNDS FOR THE TREATMENT OF VIRUS INFECTIONS | |
| ZA200305691B (en) | The use of substituted azetidione compounds for the treatment of sitosterolemia | |
| EP1390029A4 (en) | PHENYLINDOLES FOR THE TREATMENT OF HIV INFECTION | |
| IL161070A0 (en) | Compositions for the treatment of infectious diseases | |
| AU2001284645A1 (en) | Quinuclidine-substituted aryl compounds for treatment of disease | |
| GB0329874D0 (en) | Compounds useful for the treatment of diseases | |
| AU2003258145A8 (en) | Substituted phenylindoles for the treatment of hiv | |
| EP1461030A4 (en) | AMINOALKYL-BENZOFURAN-5-OL COMPOUNDS FOR THE TREATMENT OF GLAUCOMA | |
| PL369402A1 (en) | Use for the treatment of gastroesophageal reflux disease | |
| IL159511A0 (en) | Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor | |
| AU2002364711A8 (en) | Substituted 5-hydroxy-indole compounds for the treatment of glaucoma | |
| FI20011560A0 (fi) | Alfa-2B-adrenoseptorivälitteisen sairauden hoitoon tai ehkäisyyn käyttökelpoiset yhdisteet | |
| GB2392838B (en) | Calcium L-threonate for preventing or treating cartilage related diseases | |
| ZA200205835B (en) | Compounds useful for the treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor. | |
| HRP20020746A2 (en) | Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor | |
| AU2003240174A8 (en) | Compositions for the treatment of edematous-firbrosclerotic panniculopathy | |
| GB0100092D0 (en) | Treatment of degenerative diseases | |
| MXPA03006468A (es) | Composiciones para la prevencion o tratamiento de hepatopatia. | |
| HUP0400020A2 (hu) | Bőrbetegségek megelőzésére vagy kezelésére használható triciklusos vegyületet tartalmazó gyógyszerkészítmény | |
| AU2002341485A1 (en) | Treatment of polyaluminium compounds | |
| AU2002359282A1 (en) | Azabicyclic-substituted-heteroaryl compounds for the treatment of disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |